MiMedx Group, a US-based manufacturer of regenerative biomaterial products, has received three new US patents related to tissue allografts derived from the placenta. The patent number entitled Placental Tissue Grafts with number 8,409,626 ...
Tags: MiMedx, Placenta Tissue
MiMedx Group has reported positive results from a study of its EpiFix, a dehydrated human amniotic membrane allograft, designed as a treatment for diabetic neurovascular foot ulcers. The controlled, randomized trial, which enrolled 80 ...
Tags: MiMedx Group, EpiFix, dehydrated human amniotic membrane allograft
MiMedx Group, a developer of regenerative biomaterials and bioimplants, has obtained US patent for its tissue grafts derived from the placenta. The patent No.8,323,701 covers the AmnioFix brand allografts, which are produced by processing ...